Homocysteine serum levels in patients with ruptured and unruptured intracranial aneurysms: a case-control study

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Autores
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.82, n.2, p.10-10, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background There is very few data regarding homocysteine's influence on the formation and rupture of intracranial aneurysms. Objective To compare homocysteine levels between patients with ruptured and unruptured intracranial aneurysms, and to evaluate possible influences of this molecule on vasospasm and functional outcomes. Methods This is a retrospective, case-control study. We evaluated homocysteinemia differences between patients with ruptured and unruptured aneurysms; and the association of homocysteine levels with vasospasm and functional outcomes. Logistic regressions were performed. Results A total of 348 participants were included: 114 (32.8%) with previous aneurysm rupture and 234 (67.2%) with unruptured aneurysms. Median homocysteine was 10.75 mu mol/L (IQR = 4.59) in patients with ruptured aneurysms and 11.5 mu mol/L (IQR = 5.84) in patients with unruptured aneurysms. No significant association was detected between homocysteine levels and rupture status (OR = 0.99, 95% CI = 0.96-1.04). Neither mild (>15 mu mol/L; OR = 1.25, 95% CI 0.32-4.12) nor moderate (>30 mu mol/L; OR = 1.0, 95% CI = 0.54-1.81) hyperhomocysteinemia demonstrated significant correlations with ruptured aneurysms. Neither univariate (OR = 0.86; 95% CI 0.71-1.0) nor multivariable age-adjusted (OR = 0.91; 95% CI = 0.75-1.05) models evidenced an association between homocysteine levels and vasospasm. Homocysteinemia did not influence excellent functional outcomes at 6 months (mRS <= 1) (OR = 1.04; 95% CI = 0.94-1.16). Conclusion There were no differences regarding homocysteinemia between patients with ruptured and unruptured intracranial aneurysms. In patients with ruptured aneurysms, homocysteinemia was not associated with vasospasm or functional outcomes.
Palavras-chave
Homocysteine, Intracranial Aneurysm, Subarachnoid Hemorrhage, Stroke
URI
https://observatorio.fm.usp.br/handle/OPI/58925
Referências
  1. Blacher J, 2013, INT J CARDIOL, V167, P508, DOI 10.1016/j.ijcard.2012.01.060
  2. Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227
  3. Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015
  4. Dhandapani S, 2015, ACTA NEUROCHIR, V157, P399, DOI 10.1007/s00701-014-2297-0
  5. Fan R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05205-3
  6. Fowler Brian, 2005, Semin Vasc Med, V5, P77
  7. Grobelny BT, 2011, J NEUROSURG, V115, P101, DOI 10.3171/2011.2.JNS101414
  8. He YS, 2014, NUTR METAB CARDIOVAS, V24, P1158, DOI 10.1016/j.numecd.2014.05.011
  9. Hendrix P, 2018, J NEUROSURG, V128, P1771, DOI 10.3171/2017.2.JNS162933
  10. Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6
  11. Huo Y, 2015, JAMA-J AM MED ASSOC, V313, P1325, DOI 10.1001/jama.2015.2274
  12. Jin L, 2007, J PHYSIOL PHARMACOL, V58, P191
  13. Kaplan P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207698
  14. Kumar M, 2018, METAB BRAIN DIS, V33, P1617, DOI 10.1007/s11011-018-0268-5
  15. Lauretta MP, 2022, J CLIN MED, V11, DOI 10.3390/jcm11020394
  16. Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900
  17. MCCULLY KS, 1969, AM J PATHOL, V56, P111
  18. McEvoy AW, 2001, AMINO ACIDS, V21, P237, DOI 10.1007/s007260170009
  19. Osunkalu VO, 2010, J BLOOD MED, V1, P131, DOI 10.2147/JBM.S9529
  20. Quinn TJ, 2009, STROKE, V40, P3393, DOI 10.1161/STROKEAHA.109.557256
  21. Ren JR, 2017, J STROKE CEREBROVASC, V26, P2720, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.001
  22. Rosi J, 2018, WORLD NEUROSURG, V119, pE272, DOI 10.1016/j.wneu.2018.07.132
  23. Saposnik G, 2009, STROKE, V40, P1365, DOI 10.1161/STROKEAHA.108.529503
  24. Semmler A, 2008, CEREBROVASC DIS, V26, P425, DOI 10.1159/000155638
  25. Shafeeque CM, 2020, EPIGENOMICS-UK, V12, P859, DOI 10.2217/epi-2019-0280
  26. Skovierová H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101733
  27. Spence JD, 2007, LANCET NEUROL, V6, P830, DOI 10.1016/S1474-4422(07)70219-3
  28. Spence JD, 2016, INT J STROKE, V11, P744, DOI 10.1177/1747493016662038
  29. Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565
  30. Wu XY, 2020, NUTR METAB CARDIOVAS, V30, P1861, DOI 10.1016/j.numecd.2020.07.026
  31. Xu Y, 2011, NEUROSCI LETT, V494, P139, DOI 10.1016/j.neulet.2011.02.076
  32. Zhang Q, 2002, CARDIOVASC RES, V53, P1035, DOI 10.1016/S0008-6363(01)00541-7
  33. Zhang TS, 2022, FRONT SURG, V8, DOI 10.3389/fsurg.2021.813607

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE